Expand BCRX Menu
BCRX MENU

BCRX Latest Press Releases

-- July 15, 2026 --

BioCryst Appoints David W. Jenkins as Chief Scientific Officer Globe Newswire 7:00 AM

-- July 2, 2026 --

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:00 AM

-- June 29, 2026 --

BioCryst Sharpens Scientific Focus on External Innovation with Wind Down of Internal Discovery Programs and Closure of Birmingham Research Facility Globe Newswire 7:00 AM

-- June 12, 2026 --

BioCryst Presents New Clinical Data and Real-World Evidence Demonstrating Impact of HAE Portfolio at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting Globe Newswire 7:00 AM

-- June 9, 2026 --

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- May 27, 2026 --

BioCryst to Present New HAE Data from ORLADEYO (berotralstat) and Navenibart at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting Globe Newswire 7:00 AM

-- May 13, 2026 --

BioCryst to Present New Real-World Evidence Underscoring the Ongoing Burden of Pediatric Hereditary Angioedema at ISPOR 2026 Globe Newswire 7:00 AM

-- May 6, 2026 --

BioCryst Reports First Quarter 2026 Financial Results and Provides Business Update Globe Newswire 7:00 AM

-- May 5, 2026 --

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:00 AM

-- May 4, 2026 --

BioCryst Announces European Licensing Agreement with Irish Affiliate of Neopharmed Gentili for Navenibart in Hereditary Angioedema Globe Newswire 7:00 AM

-- April 28, 2026 --

BioCryst to Present at Upcoming Investor Conferences Globe Newswire 7:00 AM

-- April 15, 2026 --

BioCryst to Report First Quarter 2026 Financial Results on May 6 Globe Newswire 7:00 AM

-- April 6, 2026 --

BioCryst Appoints Sandeep M. Menon Chief Research and Development Officer Globe Newswire 7:00 AM

-- April 3, 2026 --

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:00 AM

-- March 4, 2026 --

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:00 AM

-- February 26, 2026 --

BioCryst Reports Full Year 2025 Financial Results and Provides Business Update Globe Newswire 7:00 AM

-- February 17, 2026 --

BioCryst to Present at Upcoming Investor Conference Globe Newswire 7:00 AM
Market Data Delayed 15 Minutes